STAND. COM. REP. NO. 277
RE: S.B. No. 1192
Honorable Ronald D. Kouchi
President of the Senate
Thirty-First State Legislature
Regular Session of 2021
State of Hawaii
Your Committee on Health, to which was referred S.B. No. 1192 entitled:
"A BILL FOR AN ACT RELATING TO THE ELECTRONIC PRESCRIPTION ACCOUNTABILITY SYSTEM,"
begs leave to report as follows:
The purpose and intent of this measure is to amend section 329-101(b) and (d), Hawaii Revised Statutes, to require that the dispensing of a pharmacist-prescribed opioid antagonist be reported to the State's Electronic Prescription Accountability System also known as HI-PDMP.
Your Committee received testimony in support of this measure from the Department of Health and Department of Public Safety. Your Committee received comments on this measure from Kaiser Permanente Hawaii.
Your Committee finds that this measure aligns with and supports the goals of the Hawaii Opioid Initiative to combat the national opioid crisis. Presently, efforts to track dispensing and distribution of opioid antagonists such as naloxone are decentralized. Your Committee finds that requiring pharmacists to report opioid antagonist prescriptions to the Electronic Prescription Accountability System would not be substantially burdensome and would provide the Department of Health with data useful to prevent opioid overdose.
Your Committee has amended this measure by making technical, nonsubstantive amendments for the purposes of clarity and consistency.
As affirmed by the record of votes of the members of your Committee on Health that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1192, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 1192, S.D. 1, and be referred to your Committee on Commerce and Consumer Protection.
Respectfully submitted on behalf of the members of the Committee on Health,
JARRETT KEOHOKALOLE, Chair